Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The neuroleptic malignant syndrome.

S N Caroff

    The Journal of Clinical Psychiatry
    |March 1, 1980
    PubMed
    Summary

    Neuroleptic Malignant Syndrome (NMS) is a dangerous, underdiagnosed condition caused by neuroleptic drugs. Understanding its characteristics and diagnosis is crucial for better prevention and treatment strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of tardive dyskinesia with donepezil: a pilot study.

    The Journal of clinical psychiatry·2002
    Same author

    [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].

    L'Encephale·2001
    Same author

    Treatment of tardive dyskinesia with donepezil.

    The Journal of clinical psychiatry·2001
    Same author

    Risk of fatal heatstroke after hospitalization.

    Psychiatric services (Washington, D.C.)·2000
    Same author

    Residual catatonic state following neuroleptic malignant syndrome.

    Journal of clinical psychopharmacology·2000
    Same author

    Specific treatment of the neuroleptic malignant syndrome.

    Biological psychiatry·1998

    Area of Science:

    • Pharmacology
    • Neurology
    • Clinical Medicine

    Background:

    • Neuroleptic Malignant Syndrome (NMS) is a severe adverse reaction to neuroleptic medications.
    • It is often underdiagnosed despite its potentially lethal nature.

    Purpose of the Study:

    • To review the clinical characteristics of NMS.
    • To outline the differential diagnosis of NMS.
    • To highlight the need for further research.

    Main Methods:

    • Comprehensive review of the existing world literature on NMS.
    • Analysis of reported clinical features and diagnostic criteria.

    Main Results:

    • NMS presents with specific clinical manifestations including hyperthermia, muscle rigidity, autonomic instability, and altered mental status.
    • Differential diagnosis involves distinguishing NMS from other conditions with similar symptoms.

    Conclusions:

    • NMS requires increased clinical awareness for timely diagnosis and management.
    • Further research into incidence, etiology, and pathogenesis is essential for improved prevention and treatment.
    • Enhanced understanding of NMS can advance neuroleptic pharmacology.

    Related Experiment Videos